Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q2 2025 · 10-Q
Revenue$57.83M$57.83M+8.8% vs Q2 2024 Net Income$3.43M$3.43MN/M vs Q2 2024 EPS Diluted$0.63$0.63N/M vs Q2 2024 Gross Profit$35,455,000+10.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flowderived$5,271,000−46.1% Free Cash Flowderived$3,483,000−61.9% Margins · derivedGross margin61.3%+0.9 pt vs Q2 2024
Operating margin6.1%+6.2 pt vs Q2 2024
Net margin5.9%+8.2 pt vs Q2 2024
ended Sep 30, 2024 · filed Nov 7, 2024 · 38 d after period end